Citation:Layton, A. T. , & Vallon, V. . (2018). Cardiovascular benefits of SGLT2 inhibition in diabetes and chronic kidney diseases. Acta physiologica (Oxford, England), 222, e13050. NIH Public Access.Download CitationBibTex Tagged XML
